Hydrogen Active Not Recruiting Phase 2 Trials for Neurofibromatosis Type 1 (NF1) / Cutaneous Neurofibromas / Optic Nerve Glioma Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT02839720Selumetinib in Treating Patients With Neurofibromatosis Type 1 and Cutaneous Neurofibroma